Inflammatory Astrocytes in ALS

Inflammatory Astrocytes in ALS
Taxonomy	ID
Cell Ontology (CL)	[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
Database	ID
Cell Ontology	[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
Approach	Target
Anti-inflammatory drugs	NF-κB, cytokines
GLT-1 enhancement	Glutamate transport
A1 to A2 reprogramming	Phenotype conversion
Astrocyte transplantation	Cell replacement

Introduction

Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic “A1” profile that promotes inflammation and fails to provide necessary support to motor neurons^{1Non-cell autonomous toxicity in ALS: Astrocytes and microglia. *Nat Neurosci*. 20192019 · DOI 10.1038/s41593-019-0402-7Open reference}.

The recognition of inflammatory astrocytes as key drivers of ALS pathogenesis has fundamentally changed our understanding of disease mechanisms. Rather than being passive responders to motor neuron injury, these astrocytes actively contribute to neurodegeneration through the secretion of toxic factors and loss of protective functions.

---

Overview

Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic profile that promotes inflammation and fails to provide necessary support to motor neurons.

---

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0009002)

• OBO Foundry (CL:0009002)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0009002)

• OBO Foundry (CL:0009002)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Pathological Features

Morphological Changes

• Hypertrophic cell bodies

• Increased GFAP expression

• Proliferation in spinal cord and motor cortex

• Association with motor neuron loss

Molecular Markers

The “A1” reactive astrocyte signature includes^{2Neurotoxic reactive astrocytes are induced by activated microglia. *Nature*. 20172017 · DOI 10.1038/nature21029Open reference}:

• GFAP - Upregulated intermediate filament

• C3 - Complement component C3 (A1 marker)

• Serpina3n - Acute phase protein

• Lcn2 - Lipocalin-2 (pro-inflammatory)

• Cxcl10 - Chemokine (IP-10)

---

Mechanisms of Toxicity

Secreted Factors

1. Complement components - C1q, C3 mediate synapse elimination

2. Pro-inflammatory cytokines - IL-1β, TNF-α, IL-6

3. Chemokines - CXCL10 recruits immune cells

4. Excitotoxins - Dysregulated glutamate transport

Dysfunctional Support

• Reduced glutamate clearance (GLT-1 downregulation)

• Impaired potassium buffering

• Decreased metabolic support

• Reduced neurotrophic factor secretion

Excitotoxicity

The primary mechanism of astrocyte-mediated toxicity in ALS:

• GLT-1 (EAAT2) downregulation: Reduced glutamate uptake

• Elevated extracellular glutamate: Motor neuron excitotoxicity

• AMPA/kainate receptor overactivation: Calcium influx

• Cell death: Programmed necrosis and apoptosis

---

Disease Context

Sporadic ALS

• Most common form (~90-95% of cases)

• Reactive astrocytes cluster around remaining motor neurons

• Variable A1/A2 polarization

• Variable inflammatory profiles across patients

Familial ALS

SOD1 Mutations

• Strong astrocyte involvement in pathogenesis

• Mutant SOD1 secreted by astrocytes

• Non-cell autonomous toxicity to motor neurons

• Well-characterized mouse models

C9orf72 Expansion

• DPR (dipeptide repeat) toxicity in astrocytes

• RNA foci formation

• Stress granule accumulation

• Impaired proteostasis

FUS Mutations

• RNA metabolism disruption

• Mislocalized FUS protein

• Altered transcriptional regulation

TDP-43 Pathology

• Ubiquitin dysfunction

• Aggregate formation

• Autophagy impairment

---

Astrocyte-Neuron Interaction

Direct Effects

• Physical contact with motor neurons

• Synapse elimination via complement

• Direct毒性因子分泌

Extracellular Vesicles

• Exosome-mediated toxicity

• Transfer of mutant proteins

• microRNA dysregulation

Metabolic Coupling

• Disrupted lactate shuttle

• Impaired ATP transfer

• Mitochondrial dysfunction propagation

---

Therapeutic Targets

Modulation Strategies

Experimental Approaches

1. Minocycline: Antibiotic with anti-inflammatory properties (failed in clinical trials)

2. Ceftriaxone: β-lactam antibiotic upregulates GLT-1 (failed phase 3)

3. Gene therapy: AAV-mediated GLT-1 expression

4. iPSC astrocytes: Patient-derived cells for drug screening

---

External Links

• ALS Association: https://www.als.org/

• Allen Cell Type Atlas: https://portal.brain-map.org/atlases-and-data/rnaseq

• PubMed: https://pubmed.ncbi.nlm.nih.gov/ - Biomedical literature

---

• Cell Types Index Astrocytes

• Amyotrophic Lateral Sclerosis

• Motor Neurons

• GFAP

• Excitotoxicity

---

Background

The study of Inflammatory Astrocytes In Als has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.